13 Mar

Bordetella hinzii: Zoonotic Respiratory Pathogen

Bordetella hinzii: An Emerging Zoonotic Respiratory Pathogen

Bordetella hinzii is a relatively less recognized member of the genus Bordetella, a bacterial group best known for pathogens such as Bordetella pertussis, the causative agent of whooping cough. Unlike its more famous relatives, B. hinzii primarily colonizes the respiratory tract of birds. However, increasing reports indicate that it can occasionally infect mammals, including humans, particularly those with weakened immune systems. This makes Bordetella hinzii an organism of interest in veterinary microbiology, zoonotic disease surveillance, and clinical diagnostics.

I Taxonomy & Biological Characteristics

Bordetella hinzii belongs to the phylum Proteobacteria, class Betaproteobacteria, order Burkholderiales, family Alcaligenaceae, and genus Bordetella. It is a Gram-negative, strictly aerobic coccobacillus.

Cells are small and non-spore-forming, and like other members of the genus, they require enriched media for optimal growth. Colonies on blood or chocolate agar are typically small, smooth, and grayish-white after incubation.

Molecular identification methods such as 16S rRNA gene sequencing and multilocus sequence typing are often necessary to accurately distinguish B. hinzii from closely related species including B. pertussis and B. parapertussis.

II Natural Hosts and Ecological Distribution

The ecological profile of Bordetella hinzii is strongly associated with birds.

Primary hosts: The bacterium is frequently isolated from the respiratory tract of poultry and wild birds including chickens, turkeys, ducks, parrots, and passerine birds.

Commensal behavior: In many avian hosts it exists as a commensal organism without causing obvious disease.

Opportunistic infections: Under conditions of stress, immunosuppression, or co-infection with other pathogens such as avian viruses or bacteria, B. hinzii may contribute to respiratory disease including rhinitis and tracheitis in birds.

Because the bacterium is adapted to warm-blooded hosts, its survival outside the host environment is relatively limited compared with many environmental bacteria.

III Cross-Species Infection and Zoonotic Potential

Although birds are the primary hosts, Bordetella hinzii has been identified as an opportunistic pathogen capable of infecting mammals, including humans.

Human infections are uncommon but have been reported in various clinical contexts:

Respiratory infections such as bronchitis and pneumonia
Bacteremia or septicemia in immunocompromised patients
Occasional soft tissue or biliary infections

Most reported human cases occur in individuals with underlying medical conditions such as liver disease, malignancy, organ transplantation, or other causes of immunosuppression.

In many cases, patients had direct or indirect contact with birds or poultry environments, suggesting zoonotic transmission.

IV Pathogenesis and Clinical Significance

The pathogenic mechanisms of Bordetella hinzii are not yet fully understood. However, several factors are believed to contribute to infection:

Adhesion: Bacterial surface structures such as fimbriae facilitate attachment to respiratory epithelial cells.
Toxin production: Certain enzymes and cytotoxic molecules may damage host tissues and impair mucociliary clearance.
Immune modulation: Interaction with host immune pathways may allow persistence within susceptible hosts.

Because of its ability to infect both birds and humans, B. hinzii represents a relevant example of the “One Health” concept, illustrating the interconnected health of animals, humans, and shared environments.

V Laboratory Diagnosis

Accurate diagnosis requires careful laboratory identification due to its similarity to other Gram-negative respiratory bacteria.

Sample collection: Respiratory specimens, blood cultures, or wound samples may be collected depending on the suspected infection site.

Cultivation: The bacterium can grow on blood agar or chocolate agar under aerobic conditions, producing small, smooth colonies.

Identification challenges: Conventional biochemical identification methods may misidentify B. hinzii because of overlapping characteristics with other non-fermenting Gram-negative bacteria.

Advanced identification: MALDI-TOF mass spectrometry and 16S rRNA sequencing are currently the most reliable techniques for species-level identification.

Molecular detection: PCR-based assays allow rapid and specific detection of Bordetella hinzii DNA in clinical or environmental samples.

VI Treatment and Antimicrobial Susceptibility

Antimicrobial susceptibility patterns for Bordetella hinzii differ from those of other Bordetella species.

Many isolates are susceptible to:

Third-generation cephalosporins
Fluoroquinolones
Carbapenems
Piperacillin–tazobactam
Trimethoprim–sulfamethoxazole

However, the bacterium often demonstrates resistance to ampicillin, amoxicillin-clavulanate, first-generation cephalosporins, and macrolides.

Because resistance patterns may vary, antimicrobial susceptibility testing is recommended for clinical isolates to guide treatment decisions.

VII Prevention and Risk Management

Currently, no commercial vaccine is available for Bordetella hinzii. Preventive strategies mainly focus on minimizing exposure risk and improving hygiene practices in poultry management and occupational settings.

• Use protective equipment when handling birds or poultry environments

• Maintain proper sanitation in poultry facilities

• Educate high-risk individuals such as poultry workers and veterinarians

• Improve laboratory awareness for accurate pathogen identification

Although Bordetella hinzii infections remain relatively rare, continued surveillance and molecular detection will help clarify its epidemiology and clinical significance across animal and human populations.

PCR KIT